First, we demonstrated that inhibiting PGK1 protected GDM mice by increasing estradiol levels, promoting Keap1 dimerization, activating the Nrf2-ARE pathway, and ultimately restoring mitochondrial function to mitigate OS in the placenta (Graphical Abstract). This evidence concerns the gene NFE2L2 and gestational diabetes.